Max Rosett
Chief Financial Officer · 2 filings · Latest: Jun 15, 2026
Immunome Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IMNM | Max Rosett | Chief Financial Officer | Jun 15, 2026 | Sale | $18.23 | 60,000 | $1.1M | 54,037 | |
IMNM | Max Rosett | Chief Financial Officer | Jun 15, 2026 | Option Exercise | $1.05 | 60,000 | $63.0K | 114,037 | |
IMNM | Rosett Max | — | Jun 15, 2026 | Proposed Sale | $18.63 | 60,000 | $1.1M | — | |
IMNM | Max Rosett | Chief Financial Officer | Apr 2, 2026 | Sale | $21.92 | 65,000 | $1.4M | 54,037 | |
IMNM | Max Rosett | Chief Financial Officer | Apr 2, 2026 | Option Exercise | $1.22 | 71,561 | $87.1K | 119,037 | |
IMNM | Rosett Max | — | Apr 2, 2026 | Proposed Sale | $21.92 | 65,000 | $1.4M | — | Apr 3 1:49 PM 144/A |
IMNM | Rosett Max | — | Apr 2, 2026 | Proposed Sale | $72.67 | 65,000 | $4.7M | — | |
IMNM | Rosett Max | — | Sep 19, 2024 | Proposed Sale | $16.01 | 14,380 | $230.2K | — |